| abstract |
Compound of formula (I): **(See formula)** in which A is N, R1 is -H, - an alkyl group (C1-C4), for example chosen from methyl, ethyl, propyl, isopropyl, being preferably an isopropyl, - a methylcycloalkyl (C3-C6) group, for example chosen from methylcyclopropyl and methylcyclobutyl, or - a cycloalkyl (C3-C6) group, for example a cyclopropyl, R2 is - a benzyl or a benzyl substituted with one a three groups, and in which B is N, and the group NR3R4 is chosen from: **(See formula)** or any of its pharmaceutically acceptable salts, for use in the treatment of a disease characterized by a reduction in the destruction macrophage-mediated bacteria. |